On January 27, the first 2021 annual report of Shanghai stock market was released. Specifically, Shanghai Kaikai Industry Company Limited(600272) achieved an operating revenue of 669 million yuan in 2021, a decrease of 91.9912 million yuan or 12.08% over 761 million yuan in the same period of last year. The net profit attributable to the owner of the parent company was 21.7172 million yuan, an increase of 8.0424 million yuan or 58.81% over 13.6748 million yuan in the same period of last year.
According to public information, Shanghai Kaikai Industry Company Limited(600272) is mainly engaged in the circulation of traditional Chinese medicine, traditional Chinese medicine service (TCM consultation service) and clothing wholesale and retail. The pharmaceutical sector is mainly the wholesale and retail of Chinese and Western patent medicines, the pharmaceutical care of traditional Chinese medicine with the Chinese time-honored brand “leiyunshang” as the brand, and the sales of high-end tonics of its own brand “shanglei”; The clothing sector is mainly engaged in the wholesale and retail of “Kaikai” brand shirts and sweaters and “Kaikai” brand clothing series.
